Trial Profile
A Phase 1, Open-label Study of Pralatrexate With Vitamin B12 and Folic Acid Supplementation in Patients With Relapsed or Refractory Cutaneous T-cell Lymphoma
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 07 Oct 2022
Price :
$35
*
At a glance
- Drugs Pralatrexate (Primary) ; Cyanocobalamin; Folic acid
- Indications Cutaneous T-cell lymphoma
- Focus Adverse reactions
- Sponsors Acrotech Biopharma; Allos Therapeutics
- 01 Feb 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 19 Jan 2012 Additional lead trial investigator identified as reported by ClinicalTrials.gov.
- 19 Jan 2012 Planned end date changed from 1 Jan 2012 to 1 Mar 2012 as reported by ClinicalTrials.gov record.